jeff lebrun, co-founder and ceo | [email protected] | pillsy · jeff lebrun - ceo chuks onwuneme -...
TRANSCRIPT
Jeff LeBrun, Co-Founder and CEO | [email protected] | pillsy.com
Today’s interface leads to poor adherence
125,000 premature deaths
$290 billion in preventable healthcare costs
$188 billion lost pharma revenue ($584B globally)
Sources: Network for Excellence in Health Innovation (NEHI), Capgemini Consulting
Annual Costs of Medication Non-Adherence (U.S.)
Source: RxAnte
0% 20% 40% 60% 80%
No perceived benefit!
Cost!
Confusion!
Side effects!
Forgetfulness!
Top Reasons for Medication Non-Adherence
Pillsy Helps People Manage Their Pills
SeamlessTracking
SecureSharing
EmpoweringInfo
The Pillsy Platform Smart Devices
Automatic dose tracking and smart reminders
Mobile App
Medication info, family sharing, refill reminders
Healthcare Integration
Realtime adherence data, patient management app
for pharmacies
Pillsy Advantages vs. Other Connected Pill Containers
Utilizing Bluetooth Smart vs. 3G / Cellular
n 10x Less Expensive with No Data Plan
n Much Longer Battery Life (~1yr)
Mobile App (iOS + Android)
n User Friendly & Engaging
n Easy Setup
HIPAA-Compliant Platform
Scalable – fits existing packaging
Demo video
https://vimeo.com/159737153
“Pillsy helps me feel more in control.”
- Katie S.
Pillsy User Since January
Source:http://www.vitality.net/research_harvard.html,WalgreensAdherenceReport
0%
20%
40%
60%
80%
100%
1 2 3 4 Month
Adherence to Hypertension Medication (Using Vitality Glowcaps, 2009)
Smart pill cap Control
Every 1% improvement correlates to ~$50 in healthcare cost savings.
Smart Pill Cap Studies Have Had Amazing Results
Source: M.C. Roebuck, et al. “Medication Adherence Leads to Lower Health Care Use and Costs Despite Increased Drug Spending.”
$0 $5,000 $10,000
Congestive Heart Failure
Diabetes
Hypertension
5.1 million Americans!
26 million Americans!
70 million Americans!
Cost Savings for Patients Who Adhere to Prescriptions vs. Those Who Don’t
Value Proposition to Healthcare
Large opportunity to improve adherence
100%
80%
60%
40%
20%
0%
Day 1 365 days 730 days
Typical refill pattern for maintenance medications (statins, diabetes, etc.)
Source: Journal of Managed Care Pharmacy. 2009; 15(9): 728-40
People want to use tech to manage their medications
>60% of people surveyed said they would want to use Pillsy
0%
10%
20%
30%
40%
Somewhat unlikely Neutral Somewhat likely Extremely likely
How likely would you be to use Pillsy?
Example conditions
HIV
Hepatitis
Oncology
Organ transplant
Seizures
Hemophilia
Hypertension
High cholesterol
Diabetes
Antibiotics
CHF
Allergies
Specialty Retail/Mail-order
54% of consumers say they are interested in digital alerts and reminders for their medications
- Deloitte Research
Source: Deloitte. “Improving medication adherence: Tailored approaches may boost potential for success”.
Why now?
The Pillsy Team
Experienced business and product development team, including co-founding
VC-backed startups and management experience at large tech companies.
Jeff LeBrun - CEO Chuks Onwuneme - CTO
David McIntosh - Hardware Otto Sipe - Software
Robin Callender - Firmware Dr. Nick Abraham Business Dev./Clinical
Benefits to Pharma Win more prescriptions and receive preferential coverage by payers
n Providers & pharmacists – improve their adherence ratings (affects coverage and reimbursement) n Payers – reduce preventable costs; improve their Medicare ratings and reimbursements n ACOs – all of the above
Adherence = customer retention n “Razors & blades” – patients using a drug that works with a connected device like Pillsy will lose
valuable data if they switch their prescription to a competing product n Adherent patients live longer and are more likely to continue using products
Data & User Interface n Access to detailed product usage information n Ability to survey customers within the app n Pillsy can provide copay coupons within the app
Ways to work with Pillsy 1) Create new NDC for a unique drug + packaging combination
n Enables different pricing for the “Pillsy-enabled” NDC n Providers may prescribe the combined drug + Pillsy solution to patients whom they believe could benefit
over competing, non-connected options n Help to maintain competitive advantage, even after drug is off-patent
2) Provide as aftermarket solution for existing NDCs n Example: Provide Pillsy devices to doctors or pharmacists, who can give to their patients. Devices can be
programmed to work only with a specific drug. n Pillsy will be covered by payers after demonstrating results in pilots n No regulatory approvals required
Development options n Use Pillsy’s core software – easiest, off-the-shelf option n Use Pillsy’s tech platform to develop custom mobile apps for pharmaceutical products (example: develop
an HIV management app that includes drug adherence tracking and an interface for viewing key biometrics, like T-cell counts)
n We can design devices to fit your existing packaging, so no major change to your manufacturing supply chain are needed.
